You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《匯豐輪證》澳門啟動全民核酸檢測 搏反彈之選銀河牛69618/金沙購19931
澳門最新發現四宗新冠肺炎確診個案,當局啟動全民核酸檢測,粵澳口岸出入境人員需持12小時內核酸檢測證明,香港亦將澳門納入暫不適用「回港易」的風險地區名單。澳門賭業股今早普遍受壓,其中銀河娛樂(0027)一度急插逾6.3%,低見46.85元,再創52周新低。以銀娛現價計算,由年內初二月歷史高位80.30元已急挫約40%,回調之深近日同時吸引好淡倉作部署,過去五日淡倉累計淨流入約6,600萬元,好倉亦有5,500萬元,資金流未有方向性指標。 大行報告指澳門7月賭收大致符該行及市場預期,料8月賭收約85億元,如看好澳門賭收穩步增長,帶動銀河股價反彈可參考銀河牛證69618,收回價 44.88 元,2022年3月到期,實際槓桿 11.4 倍。另外金沙中國(1928)今早一度跌穿去年3月疫情爆發後的底部約25.15元,失守25元後走勢回順。欲趁勢博反彈可留意金沙認購證19931,行使價 36.05 元,2022年1月到期,實際槓桿 7.9 倍。 陳恩因 匯豐環球資本市場機構客戶及財富管理聯席總監 更新日期及時間: 2021年8月4日 上午11:50 本結構性產品並無抵押品,如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。 本文由香港上海匯豐銀行有限公司(「本行」或「發行商」)發行(包括任何參考條款),僅供參考之用,並不構成邀約、游說、或建議出售或購買結構性產品。 結構性產品屬複雜產品,投資者務須就此審慎行事,除非投資者完全了解及願意承擔所涉風險,否則切勿投資此產品。結構性產品價格可急升可急跌,投資者或會損失所有或大部分投資。過往表現並不反映將來表現。投資前應了解結構性產品之性質及風險,並詳閱有關上市文件,獨立決定是否適合自己,若需要應諮詢專業建議。本行及其委任之流通量提供者可能是結構性產品的唯一市場參與者,而結構性產品的二級市場可能有限。謹請注意,牛熊證設有強制收回機制,因此有可能提早終止,在此情況下(i)N類牛熊證投資者會損失於牛熊證的全部投資;而(ii)R類牛熊證之剩餘價值則可能為零。 作者為金管局及證監會持牌人士,並無就結構性產品或相關資產持有任何直接或間接權益。~ 重要聲明: 以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account